To access this element change to forms mode OFF
Grant Award View - GA205196
Harnessing a novel immune check point for cancer killing
GA ID:
GA205196
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
13-Dec-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2025
Value (AUD):
$924,922.20
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Harnessing a novel immune check point for cancer killing
Purpose:
The Project Team aims to test the idea that a patients T cells can be ‘tuned’ to increase the ability of their own immune system to find, infiltrate, and kill pancreatic cancer cells.This may be beneficial as a stand alone therapy or most likely, work in synergy with emerging immune therapies.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2011763
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Sydney
Town/City:
Sydney
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NSW, SA
Postcode:
Multiple
Country:
AUSTRALIA